**Press Release Summary: India’s Growing Strength in the Pharmaceutical Sector**
**Source:** Prime Minister’s Office (PIB Delhi)
**Date of Publication:** April 14, 2026, 1:11 PM
**Release ID:** 2251811
**Overview**
Prime Minister Shri Narendra Modi has shared an article authored by Union Minister Shri Jagat Prakash Nadda regarding the strategic evolution of India’s pharmaceutical sector. The publication details India’s transition from its traditional role as the “pharmacy of the world” to becoming a global hub for innovation and high-value research.
**Key Strategic Focus Areas**
Under the current government’s policy framework, the pharmaceutical sector is moving up the value chain by prioritizing the following areas:
* **Research and Development (R&D):** Implementation of extensive R&D initiatives to lead the global pharmaceutical market.
* **Advanced Medical Products:** A dedicated focus on the development of biologics and biosimilars.
* **Modern Medicine:** Investment and research into cutting-edge therapies.
**Digital and Media References**
The Prime Minister’s Office (PMO) emphasized these advancements via the social media platform X (@PMOIndia). The communication highlighted a retrospective piece by Shri J.P. Nadda, originally published in *The Hindu Business Line*, which outlines India’s roadmap for global leadership in this sector.
**Document Details and Metadata**
* **Visitor Counter:** 383
* **Article Reference:** [India Moving Up the Pharma Value Chain](https://www.thehindubusinessline.com/opinion/india-moving-up-the-pharma-value-chain/article70858640.ece)
* **Available Languages:** The release is accessible in Urdu, Marathi, Hindi, Bengali, Manipuri, Assamese, Gujarati, Telugu, and Kannada.
Key Entities Referenced
India’s Pharma Sector: The primary industry focus, transitioning from being the 'pharmacy of the world' to a global hub for innovation and R&D.
Shri Jagat Prakash Nadda: Union Minister and author of the article detailing the government's strategic focus on the pharmaceutical value chain.
India moving up the pharma value chain: The referenced article outlining the policy shift toward extensive R&D, biologics, biosimilars, and cutting-edge therapies.
Prime Minister's Office
Prime Minister shares an article on India’s
growing strength in the pharma sector
Posted On: 14 APR 2026 1:11PM by PIB Delhi
The Prime Minister, Shri Narendra Modi, has shared an article written by Union Minister, Shri Jagat
Prakash Nadda.
The article highlights that India’s pharma sector is moving from being the “pharmacy of the world” to a
hub of innovation. It notes that under the present government, the focus has been on extensive research
and development, biologics, biosimilars and cutting-edge therapies, as India prepares to lead the global
race in this sector.
The Prime Minister’s Office posted on X;
“From the “pharmacy of the world” to a hub of innovation, India’s pharma sector is moving up the value
chain. Under the present government, the focus has been on extensive R&D, biologics, biosimilars and
cutting-edge therapies.
A must-read retrospection by Union Minister Shri @JPNadda on how India is preparing to lead the global
race in this sector!
https://www.thehindubusinessline.com/opinion/india-moving-up-the-pharma-value-chain/article70858640.
ece”
From the “pharmacy of the world” to a hub of innovation, India’s pharma sector is
moving up the value chain. Under the present government, the focus has been on
extensive R&D, biologics, biosimilars and cutting-edge therapies.
A must-read retrospection by Union Minister Shri… pic.twitter.com/zITsjGI9oV
— PMO India (@PMOIndia) April 14, 2026
****
MJPS/ST
(Release ID: 2251811) Visitor Counter : 383
Read this release in: Urdu , Marathi , ही , Bengali , Manipuri , Assamese , Gujarati , Telugu , Kannada